260 related articles for article (PubMed ID: 22342763)
21. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L
Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.
Hawong HY; Patterson JR; Winner BM; Goudreau JL; Lookingland KJ
Brain Res; 2015 Oct; 1622():240-51. PubMed ID: 26141374
[TBL] [Abstract][Full Text] [Related]
24. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Jackson-Lewis V; Jakowec M; Burke RE; Przedborski S
Neurodegeneration; 1995 Sep; 4(3):257-69. PubMed ID: 8581558
[TBL] [Abstract][Full Text] [Related]
25. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
Ding H; Underwood R; Lavalley N; Yacoubian TA
Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
[TBL] [Abstract][Full Text] [Related]
26. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
[TBL] [Abstract][Full Text] [Related]
27. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
[TBL] [Abstract][Full Text] [Related]
28. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
Kozina EA; Kim AR; Kurina AY; Ugrumov MV
Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
[TBL] [Abstract][Full Text] [Related]
29. Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
Sai T; Uchida K; Nakayama H
J Toxicol Sci; 2013; 38(3):445-58. PubMed ID: 23665943
[TBL] [Abstract][Full Text] [Related]
30. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.
Clark J; Silvaggi JM; Kiselak T; Zheng K; Clore EL; Dai Y; Bass CE; Simon DK
PLoS One; 2012; 7(11):e48925. PubMed ID: 23145024
[TBL] [Abstract][Full Text] [Related]
31. Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Aguiar AS; Tristão FS; Amar M; Chevarin C; Lanfumey L; Mongeau R; Corti O; Prediger RD; Raisman-Vozari R
Neurotox Res; 2013 Aug; 24(2):280-7. PubMed ID: 23588969
[TBL] [Abstract][Full Text] [Related]
32. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
Zhang J; Graham DG; Montine TJ; Ho YS
J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
Crocker SJ; Smith PD; Jackson-Lewis V; Lamba WR; Hayley SP; Grimm E; Callaghan SM; Slack RS; Melloni E; Przedborski S; Robertson GS; Anisman H; Merali Z; Park DS
J Neurosci; 2003 May; 23(10):4081-91. PubMed ID: 12764095
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.
Thomas B; Banerjee R; Starkova NN; Zhang SF; Calingasan NY; Yang L; Wille E; Lorenzo BJ; Ho DJ; Beal MF; Starkov A
Antioxid Redox Signal; 2012 May; 16(9):855-68. PubMed ID: 21529244
[TBL] [Abstract][Full Text] [Related]
35. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
Sun X; Xiong Z; Zhang Y; Meng Y; Xu G; Xia Z; Li J; Zhang R; Ke Z; Xia Z; Hu Y
J Neurochem; 2012 Mar; 120(6):1072-83. PubMed ID: 22192054
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Bian M; Liu J; Hong X; Yu M; Huang Y; Sheng Z; Fei J; Huang F
PLoS One; 2012; 7(6):e39953. PubMed ID: 22792139
[TBL] [Abstract][Full Text] [Related]
37. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
38. The mouse MPTP model: gene expression changes in dopaminergic neurons.
Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC
Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964
[TBL] [Abstract][Full Text] [Related]
39. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
[TBL] [Abstract][Full Text] [Related]
40. Dorsal hypothalamic dopaminergic neurons play an inhibitory role in the hypothalamic-pituitary-adrenal axis via activation of D2R in mice.
Di T; Chen P; Yuan Z; Wang Y; Sha S; Chen L
Acta Physiol (Oxf); 2019 Feb; 225(2):e13187. PubMed ID: 30204307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
